Outcome of patients with metastatic sarcomatoid renal cell carcinoma: Results from the international metastatic renal cell carcinoma database consortium

Clinical Genitourinary Cancer

Volumn 13, Issue 2, 2015, Pages e79-e85

  Kyriakopoulos, Christos E ^a   Chittoria, Namita ^a   Choueiri, Toni K ^b   Kroeger, Nils ^c   Lee, Jae Lyun ^d   Srinivas, Sandy ^e   Knox, Jennifer J ^f   Bjarnason, Georg A ^g   Ernst, Scott D ^h   Wood, Lori A ⁱ   Vaishampayan, Ulka N ^j   Agarwal, Neeraj ^k   Pal, Sumanta K ^l   Kanesvaran, Ravindran ^m   Rha, Sun Young ⁿ   Yuasa, Takeshi ^o   Donskov, Frede ^p   North, Scott A ^q   Heng, Daniel Y ^r   Rini, Brian I ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^d University of Ulsan College of Medicine   (South Korea)

^e STANFORD CANCER INSTITUTE   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j WAYNE STATE UNIVERSITY   (United States)

^k UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^l CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^m DIVISION OF MEDICAL ONCOLOGY   (Singapore)

ⁿ Yonsei University College of Medicine   (South Korea)

^o CANCER INSTITUTE HOSPITAL   (Japan)

^p AARHUS UNIVERSITY HOSPITAL   (Denmark)

^q UNIVERSITY OF ALBERTA   (Canada)

^r UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

IMDC risk model; Kidney cancer; Overall survival; Prognostication; Targeted therapies

Indexed keywords

AXITINIB; BEVACIZUMAB; EVEROLIMUS; PAZOPANIB; SORAFENIB; SUNITINIB; TEMSIROLIMUS; TIVOZANIB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; VASCULOTROPIN A;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM METASTASIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT RISK; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SARCOMATOID CARCINOMA; SARCOMATOID RENAL CELL CARCINOMA; SYSTEMIC THERAPY; TIME TO TREATMENT; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; CARCINOMA, RENAL CELL; FACTUAL DATABASE; KIDNEY NEOPLASMS; METASTASIS; PATHOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DATABASES, FACTUAL; HUMANS; KIDNEY NEOPLASMS; MOLECULAR TARGETED THERAPY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84924619957     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.08.011     Document Type: Article

References (19)

1. B.I. Rini, S.C. Campbell, and B. Escudier Renal cell carcinoma Lancet 373 2009 1119 1132
2. A. Lopez-Beltran, M. Scarpelli, R. Montironi, and Z. Kirkali 2004 WHO classification of the renal tumors of the adults Eur Urol 49 2006 798 805
3. A. Lopez-Beltran, J.C. Carrasco, L. Cheng, M. Scarpelli, Z. Kirkali, and R. Montironi 2009 update on the classification of renal epithelial tumors in adults Int J Urol 16 2009 432 443
4. B. Delahunt, J.C. Cheville, and G. Martignoni The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters Am J Surg Pathol 37 2013 1490 1504
5. J.C. Cheville, C.M. Lohse, and H. Zincke Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome Am J Surg Pathol 28 2004 435 441
6. M. de Peralta-Venturina, H. Moch, and M. Amin Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases Am J Surg Pathol 25 2001 275 284
7. T.D. Jones, J.N. Eble, M. Wang, G.T. Maclennan, S. Jain, and L. Cheng Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation Cancer 104 2005 1195 1203
8. B. Shuch, G. Bratslavsky, W.M. Linehan, and R. Srinivasan Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies Oncologist 17 2012 46 54
9. A.R. Golshayan, S. George, and D.Y. Heng Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy J Clin Oncol 27 2009 235 241
10. A.M. Molina, S.K. Tickoo, and N. Ishill Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease Am J Clin Oncol 34 2011 454 459
11. D.M. Nanus, A. Garino, M.I. Milowsky, M. Larkin, and J.P. Dutcher Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma Cancer 101 2004 1545 1551
12. N.B. Haas, X. Lin, and J. Manola A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802 Med Oncol 29 2012 761 767
13. B. Escudier, J.P. Droz, and F. Rolland Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers J Urol 168 2002 959 961
14. M. Staehler, N. Haseke, and A. Roosen Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation Eur J Med Res 15 2010 287 291
15. D.Y. Heng, W. Xie, and M.M. Regan Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794 5799
16. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
17. N.M. Tannir, E. Plimack, and C. Ng A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma Eur Urol 62 2012 1013 1019
18. J.P. Dutcher, and D. Nanus Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy Med Oncol 28 2011 1530 1533
19. D. Michelson, D.F. McDermott, and M.B. Atkins Phase II trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma J Clin Oncol 28 2010 e15076